Abstract
In this article, the authors apply Alan Gewirth’s Principle of Generic Consistency. They argue that a defensible approach to medical research must give proper place to the problem of allocating any consequent advances in accordance with the moral rights and status of all agents. When this is done, they contend that some advances that cannot be given to everyone ought not to be available to anyone and certain types of applied medical research should not be conducted. This suggests that, when seen in the context of scarcity of resources, situations where the benefits of medical research can legitimately override the rights of research subjects are far more limited than is often recognised.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this chapter
Cite this chapter
Beyleveld, D., Pattinson, S.D. (2004). Individual Rights, Social Justice, and the Allocation of Advances in Biotechnology. In: Boylan, M. (eds) Public Health Policy and Ethics. International Library of Ethics, Law, and the New Medicine, vol 19. Springer, Dordrecht. https://doi.org/10.1007/1-4020-2207-7_4
Download citation
DOI: https://doi.org/10.1007/1-4020-2207-7_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-1762-9
Online ISBN: 978-1-4020-2207-4
eBook Packages: MedicineMedicine (R0)